Smithers to exhibit at Drug Delivery to the Lungs Conference, Edinburgh, UK, 12-14 December 2018

DDL provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.

Join Smithers experts Andrew Feilden and Eleanor Canipa at stand 167 to find out more about our testing services and how we can help with your upcoming projects.

Smithers Chemistry Operations Director Dr Andrew Feilden says “We’re really pleased to be back at DDL this year and looking forward to exploring the latest developments in drug delivery and inhalation. There are some great lectures to look forward to, including the DDL Lecture on ‘Mechanistic Understanding of Microparticle Formation in Respiratory Applications’ and ‘Three drugs in one inhaler for COPD: where are we going with triple therapy’. It looks set to be a great event.”

Smithers offers a range of testing services for the medical and pharmaceutical industries, supporting you at every part of your path to market. Our services help clients demonstrate compliance to regulatory guidance or specifications set out by the FDA, EMA, MHRA, USP, ASTM and ISO:

  • Pharmaceutical and Medical Device Chemical Analysis
  • Drug Delivery Device and Accessories Testing
  • Healthcare Product and Packaging Validation
  • Support Demonstrating Regulatory Compliance
  • Materials Selection, Characterisation and Testing

Find out more:

Medical and Pharmaceutical Testing Services 

DDL 2018